Unknown

Dataset Information

In silico mining identifies IGFBP3 as a novel target of methylation in prostate cancer.


ABSTRACT: Promoter hypermethylation is central in deregulating gene expression in cancer. Identification of novel methylation targets in specific cancers provides a basis for their use as biomarkers of disease occurrence and progression. We developed an in silico strategy to globally identify potential targets of promoter hypermethylation in prostate cancer by screening for 5' CpG islands in 631 genes that were reported as downregulated in prostate cancer. A virtual archive of 338 potential targets of methylation was produced. One candidate, IGFBP3, was selected for investigation, along with glutathione-S-transferase pi (GSTP1), a well-known methylation target in prostate cancer. Methylation of IGFBP3 was detected by quantitative methylation-specific PCR in 49/79 primary prostate adenocarcinoma and

SUBMITTER: Perry AS 

PROVIDER: S-EPMC2359953 | biostudies-literature | 2007 May

REPOSITORIES: biostudies-literature